Total Payments
$714.14
2024 Payments
$245.50
Companies
9
Transactions
13
Medicare Patients
674
Medicare Billing
$110,229
Payment Breakdown by Category
Food & Beverage$714.14 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $714.14 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biocompatibles, Inc. | $142.10 | 2 | $0 (2017) |
| W. L. Gore & Associates, Inc. | $133.51 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $118.26 | 1 | $0 (2018) |
| ABBVIE INC. | $88.04 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $74.77 | 1 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $74.58 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $32.59 | 2 | $0 (2024) |
| ORPHALAN INC | $30.07 | 1 | $0 (2024) |
| Celltrion USA Inc. | $20.22 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.50 | 8 | ABBVIE INC. ($88.04) |
| 2023 | $74.77 | 1 | Gilead Sciences, Inc. ($74.77) |
| 2018 | $251.77 | 2 | W. L. Gore & Associates, Inc. ($133.51) |
| 2017 | $142.10 | 2 | Biocompatibles, Inc. ($142.10) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Hepatology | ||||||
| 10/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Rare Disease | ||||||
| 09/19/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Rare Disease | ||||||
| 08/27/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Rare Disease | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Gastroenterology | ||||||
| 03/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $88.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $74.77 | General |
| 10/24/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $118.26 | General |
| 06/13/2018 | W. L. Gore & Associates, Inc. | VIATORR TIPS Endoprosthesis (Device) | Food and Beverage | In-kind items and services | $133.51 | General |
| Category: Devices | ||||||
| 10/30/2017 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Food and Beverage | In-kind items and services | $72.56 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 10/30/2017 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Food and Beverage | In-kind items and services | $69.54 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 132 | 224 | $59,589 | $22,174 |
| 2022 | 7 | 163 | 273 | $77,476 | $26,504 |
| 2021 | 7 | 225 | 360 | $100,329 | $36,270 |
| 2020 | 7 | 154 | 302 | $82,735 | $25,280 |
Total Patients
674
Total Services
1,159
Medicare Billing
$110,229
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 34 | 77 | $24,640 | $8,901 | 36.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 66 | $16,698 | $6,716 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 31 | $6,851 | $2,576 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $5,505 | $1,716 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $2,652 | $1,194 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 23 | $3,243 | $1,072 | 33.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 120 | $30,360 | $10,515 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 32 | 41 | $13,120 | $4,711 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 36 | 47 | $10,387 | $3,701 | 35.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 22 | $10,912 | $3,405 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $6,973 | $2,144 | 30.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,032 | $1,394 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 12 | $1,692 | $633.87 | 37.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 52 | 129 | $32,637 | $11,321 | 34.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 43 | 70 | $22,400 | $8,966 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 35 | 62 | $13,702 | $5,050 | 36.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 26 | $12,896 | $4,173 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 21 | 21 | $7,707 | $2,397 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 14 | $3,094 | $1,570 | 50.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 23 | 25 | $3,525 | $1,433 | 40.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $4,368 | $1,359 | 31.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 41 | 131 | $35,550 | $11,702 | 32.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 31 | 60 | $19,610 | $5,355 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 27 | 45 | $10,190 | $2,908 | 28.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 19 | 30 | $6,300 | $2,008 | 31.9% |
About Dr. Costica Aloman, M.D
Dr. Costica Aloman, M.D is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629277652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Costica Aloman, M.D has received a total of $714.14 in payments from pharmaceutical and medical device companies, with $245.50 received in 2024. These payments were reported across 13 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($714.14).
As a Medicare-enrolled provider, Aloman has provided services to 674 Medicare beneficiaries, totaling 1,159 services with total Medicare billing of $110,229. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Gastroenterology
- Location Valhalla, NY
- Active Since 07/11/2007
- Last Updated 06/10/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629277652
Products in Payments
- THERASPHERE - BIO (Device) $142.10
- VIATORR TIPS Endoprosthesis (Device) $133.51
- CREON (Drug) $88.04
- IQIRVO (Drug) $74.58
- XIFAXAN (Drug) $32.59
- CUVRIOR (Drug) $30.07
- ZYMFENTRA (Biological) $20.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Internal Medicine $96,684
Luciano De Marco, M.d, M.D
Internal Medicine — Payments: $14,149
Internal Medicine $14,149
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Internal Medicine $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Internal Medicine $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Internal Medicine $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880
Internal Medicine $2,880